Concepedia

Yu Du

YD

6

Publications

366

Citations

6

H-Index

2000

Active since

Affiliations

Weifang Medical University(Current)

The University of Texas MD Anderson Cancer Center

Yu Du is an author at Weifang Medical University specializing in tumor biology, medicine, and cancer cell biology.

ORCID

Top concepts

Publications per year

2000–2019

6

Publications

6

PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer

Tingting Yang, Chune Ren, Pengyun Qiao et al. · Oncogene · 2018 · 129 citations · Full text

Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer

Tingting Yang, Chune Ren, Pengyun Qiao et al. · Oncogene · 2019 · 90 citations · Full text

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.

Claire F. Verschraegen, Wei Hu, Yu Du et al. · PubMed · 2003 · 56 citations

Negative regulation of AMPKα1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer

Xue Han, Chune Ren, Tingting Yang et al. · Oncogene · 2019 · 46 citations

, , +10

<scp>PIM</scp>2 interacts with tristetraprolin and promotes breast cancer tumorigenesis

Chune Ren, Tingting Yang, Pengyun Qiao et al. · Molecular Oncology · 2018 · 29 citations · Full text

Rows per page

1–5 of 6